Clinical Trials and Research Display
|Title||A Comparison of the CNS Effects of Equivalent Doses of Escitalopram and Racemic Citalopram Using BOLD fMRI|
|Sponsor||Caritas St. Elizabeth's Medical Center of Boston|
- St. Elizabeth's Medical Center (Recruiting)
|Global Trial Status||Recruiting|
|Study Phase||Phase 4|
Other Trial Information
Trial Rationale and Purpose
Escitalopram (Lexapro) and citalopram (Celexa) are similar selective serotonin reuptake
inhibitors that alter blood flow to the amygdala and other brain structures involved in
regulating mood. Escitalopram consists of S-citalopram while citalopram contains both
S-citalopram and R-citalopram (racemic citalopram). There is evidence that R-citalopram may
block the effects of S-citalopram. The hypothesis being tested is that because of the
antagonist effect of R-citalopram, S-citalopram will have a greater effect on the mood
circuit than racemic citalopram when equal doses of S-citalopram are administered.
Trial Inclusion/Exclusion Criteria
- Healthy male aged 21 to 50 years.
- Capable of providing informed consent.
- Has an established residence and phone.
- Meets DSM-IV criteria for an Axis I or II disorder.
- History of substance dependence or abuse within the past month.
- Use of NSAID's, beta blockers, calcium channel blockers, antidepressants,
antipsychotic medications, lithium or other medication which in the opinion of the
investigator would alter vascular responsivity.
- Regular use of sedative hypnotic or narcotic medication, or other medication that
might affect the individual's perception of visual stimuli.
- History of cataracts or significant visual impairment.
- A medical condition, which in the opinion of the investigator is likely to affect the
individual's perception of the visual stimuli or vascular response.
- Participation in a research protocol that included administration of medication
within the past 3 months.
- Cigarette smoking.